Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 12, 2021
[An Autopsy Case of IGF‒Ⅱ Secreting Gastric Cancer with Non‒Islet Cell Tumor Hypoglycemia]
Taro Ueda, Masashi Namba, Tadashi Senoo, et al.
Internal Medicine (Tokyo, Japan)
|
October 13, 2017
Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis
Masashi Namba, Takeshi Masuda, Takashi Nakamura, et al.
Pacing and Clinical Electrophysiology : PACE
|
June 16, 2005
Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population
Hiroki Oe, Masahiko Takagi, Atsushi Tanaka, et al.
Stem Cell Research & Therapy
|
August 24, 2021
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
Hiroshi Takahashi, Taku Nakashima, Takeshi Masuda, et al.
Respiratory Medicine
|
April 1, 2023
Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases
Taku Nakashima, Keitaro Omori, Masashi Namba, et al.
BMJ Open Respiratory Research
|
February 20, 2024
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis
Shinichiro Miura, Hiroshi Iwamoto, Masashi Namba, et al.
Cancer Letters
|
November 4, 2018
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1
Masashi Namba, Noboru Hattori, Hironobu Hamada, et al.
Journal of Cellular and Molecular Medicine
|
February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts
Takeshi Masuda, Taku Nakashima, Masashi Namba, et al.
Stem Cell Research & Therapy
|
September 17, 2021
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
Shun Takao, Taku Nakashima, Takeshi Masuda, et al.
Cancers
|
February 25, 2023
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 12, 2021
[An Autopsy Case of IGF‒Ⅱ Secreting Gastric Cancer with Non‒Islet Cell Tumor Hypoglycemia]
Taro Ueda, Masashi Namba, Tadashi Senoo, et al.
Internal Medicine (Tokyo, Japan)
|
October 13, 2017
Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis
Masashi Namba, Takeshi Masuda, Takashi Nakamura, et al.
Pacing and Clinical Electrophysiology : PACE
|
June 16, 2005
Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population
Hiroki Oe, Masahiko Takagi, Atsushi Tanaka, et al.
Stem Cell Research & Therapy
|
August 24, 2021
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
Hiroshi Takahashi, Taku Nakashima, Takeshi Masuda, et al.
Respiratory Medicine
|
April 1, 2023
Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases
Taku Nakashima, Keitaro Omori, Masashi Namba, et al.
BMJ Open Respiratory Research
|
February 20, 2024
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis
Shinichiro Miura, Hiroshi Iwamoto, Masashi Namba, et al.
Cancer Letters
|
November 4, 2018
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1
Masashi Namba, Noboru Hattori, Hironobu Hamada, et al.
Journal of Cellular and Molecular Medicine
|
February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts
Takeshi Masuda, Taku Nakashima, Masashi Namba, et al.
Stem Cell Research & Therapy
|
September 17, 2021
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
Shun Takao, Taku Nakashima, Takeshi Masuda, et al.
Cancers
|
February 25, 2023
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, et al.
Page
of 3